Type / Class
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
Shares outstanding
49.7M
Number of holders
94
Total 13F shares, excl. options
30.5M
Shares change
-1.33M
Total reported value, excl. options
$759M
Value change
-$4.81M
Put/Call ratio
0.75
Number of buys
40
Number of sells
-45
Price
$24.90

Significant Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q1 2024

115 filings reported holding BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share as of Q1 2024.
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30.5M shares of 49.7M outstanding shares and own 61.29% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4.94M shares), Deep Track Capital, LP (3.49M shares), Paradigm Biocapital Advisors LP (3.25M shares), ARMISTICE CAPITAL, LLC (1.67M shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (1.55M shares), MORGAN STANLEY (1.52M shares), First Light Asset Management, LLC (1.19M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.04M shares), Polar Capital Holdings Plc (1M shares), and SUVRETTA CAPITAL MANAGEMENT, LLC (914K shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.